Margins have been in the low 80% on average. As revenues expand and margins stay in the 75-83% range the company should start making money. Profitable Biotechs are very rare. Plus at 5X sales for most takeovers that would be around 3X from here.
If they meet the revenue guidelines they have put out in public a number of times, the stock price will take care of itself.
I hope we get a few more quarters of growth behind us before getting bought out. It would be best to get to the $100 million in revenue mark and receive a 4-6x revenues offer in two years... All good!
Recent ghost town trading pattern pre-earnings release . Expect to see a quick double to $4-$5 on a gap up . Then steady out perform . This should be a $10 stock .
Smarterthanthou on Nov 18th with BONE at $3.00, you said: if I could cough up enough money to buy more right now I surely would .None the less I am content with 4500 shares that should easily triple from here given a little time and patience .Well you would be down almost another 30% if you had.